RxDoctor Payments Data

Victor Benitez Collazo, MD

Internal Medicine · Ponce, PRNPI 1518047323

Payments from drug & device makers

$1,002in general payments, 2019–2025

Across 45 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$247
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$207
  • AstraZeneca$151
  • Johnson & Johnson$149
  • E.r. Squibb & Sons, L.L.C.$73
  • Boston Scientific$70
  • plus $106 from 4 others

What the payments were for

  • Food & beverage$99799%
  • Education$51%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,002 in reported general payments places this provider in the 60th percentile of 1,043 internal medicine providers in Puerto Rico.

See all internal medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,339
Medicare patients
25
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate139$110,992
FarxigaDapagliflozin Propanediol97$76,716
JanumetSitagliptin Phos/Metformin Hcl71$57,618
TradjentaLinagliptin86$55,909
EliquisApixaban79$52,349
JardianceEmpagliflozin60$49,202
EntrestoSacubitril/Valsartan68$46,817
XareltoRivaroxaban43$32,344
SynthroidLevothyroxine Sodium393$30,798
Omega-3 Acid Ethyl Esters319$20,330
TrulicityDulaglutide18$17,315
LantusInsulin Glargine,hum.Rec.Anlog116$14,896
BrilintaTicagrelor26$13,804
Humalog Kwikpen U-200Insulin Lispro17$11,082
Stiolto RespimatTiotropium Br/Olodaterol Hcl21$10,772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Janumet Xr$12$178,338221 claims
AstraZenecaFarxiga, Brilinta$151$90,520123 claims
Johnson & JohnsonXarelto$149$32,34443 claims
Sanofi-aventis U.S. LLCLantus$247$14,896116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,043 internal medicine providers in Puerto Rico.

Other internal medicine in Ponce

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →